Cl‐IB‐MECA decreased proliferation, arrested the cell cycle at the G1 phase, and facilitated chemosensitivity by downregulating MDR1 and ABCB1 in pancreatic and hepatocellular carcinoma cell lines [24]. Here, ABCB1 is linked to hepatocellular carcinoma.